ATE372763T1 - Verwendung von ascorbinsäure zur verstärkung der dermo-epidermischen bindung - Google Patents

Verwendung von ascorbinsäure zur verstärkung der dermo-epidermischen bindung

Info

Publication number: ATE372763T1
Authority: AT; Austria
Prior art keywords: synthesis; ascorbic acid; dermo; epidermal; strengthen
Prior art date: 2002-02-07

Application number

AT03290275T

Other languages

English (en)

Inventor

Francoise Bernerd

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-07

Filing date

2003-02-04

Publication date

2007-09-15

2003-02-04 Application filed by Oreal filed Critical Oreal

2007-09-15 Application granted granted Critical

2007-09-15 Publication of ATE372763T1 publication Critical patent/ATE372763T1/de

Links

230000015572 biosynthetic process Effects 0.000 abstract 4
238000003786 synthesis reaction Methods 0.000 abstract 4
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
102000004510 Collagen Type VII Human genes 0.000 abstract 2
108010017377 Collagen Type VII Proteins 0.000 abstract 2
102000007000 Tenascin Human genes 0.000 abstract 2
108010008125 Tenascin Proteins 0.000 abstract 2
239000002537 cosmetic Substances 0.000 abstract 2
230000001737 promoting effect Effects 0.000 abstract 2
229960005070 ascorbic acid Drugs 0.000 abstract 1
235000010323 ascorbic acid Nutrition 0.000 abstract 1
239000011668 ascorbic acid Substances 0.000 abstract 1
230000007812 deficiency Effects 0.000 abstract 1
239000001963 growth medium Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000002609 medium Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Gerontology & Geriatric Medicine (AREA)
Transplantation (AREA)
Birds (AREA)
Oral & Maxillofacial Surgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)

AT03290275T 2002-02-07 2003-02-04 Verwendung von ascorbinsäure zur verstärkung der dermo-epidermischen bindung ATE372763T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0201510A FR2835429B1 (fr)	2002-02-07	2002-02-07	Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique

Publications (1)

Publication Number	Publication Date
ATE372763T1 true ATE372763T1 (de)	2007-09-15

Family

ID=27589606

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03290275T ATE372763T1 (de)	2002-02-07	2003-02-04	Verwendung von ascorbinsäure zur verstärkung der dermo-epidermischen bindung

Country Status (5)

Country	Link
EP (1)	EP1334714B1 (de)
AT (1)	ATE372763T1 (de)
DE (1)	DE60316209T2 (de)
ES (1)	ES2292917T3 (de)
FR (1)	FR2835429B1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100645090B1 (ko) *	2005-01-13	2006-11-23	(주)트리코진	비타민 ｃ 및 그 유도체를 포함하는 탈모 치료제 조성물
FR2924335B1 (fr) *	2007-11-30	2016-03-25	Lvmh Rech	Utilisation de l'acide 2-glucoside ascorbique dans une composition cosmetique contre le vieillissement.
FR2924334B1 (fr) *	2007-11-30	2016-03-25	Lvmh Rech	Composition cosmetique comprenant l'acide 2-glucoside ascorbique et l'ergothioneine.
FR2940612B1 (fr)	2008-12-30	2011-05-06	Oreal	Association de monosaccharides avec l'acide ascorbique et son utilisation en cosmetique
DE102013018981A1 (de) *	2013-11-13	2015-05-13	Bernd Degen	Verfahren zur Herstellung eines Pflanzenextrakts
US10273549B2 (en)	2016-04-21	2019-04-30	Vitrolabs Inc.	Engineered skin equivalent, method of manufacture thereof and products derived therefrom
FR3154322A1 (fr) *	2023-10-24	2025-04-25	L'oreal	Composition cosmétique transparente avec acide ascorbique et polymère naturel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2612775B1 (fr) *	1987-03-25	1991-10-11	Thorel Jean	Compositions pour la prevention et le traitement de la degenerescence cutanee
FR2730635B1 (fr) *	1995-02-17	1997-05-09	Lvmh Rech	Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant un extrait de bertholletia
FR2733148B1 (fr) *	1995-04-20	1997-05-30	Oreal	Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
FR2779059B1 (fr) *	1998-05-29	2004-09-10	Guerlain	Procede de traitement cosmetique pour lutter contre les effets du vieillissement cutane; nouvelles compositions cosmetiques pour sa mise en oeuvre
FR2770776B1 (fr) *	1997-11-07	2000-03-17	Lvmh Rech	Utilisations du d-xylose et de ses esters pour ameliorer la fonctionnalite des cellules de l'epiderme
US6403108B1 (en) *	2000-03-31	2002-06-11	Sheikh Ahmed Abdullah	Cosmetic composition and method of use
AU2001286578A1 (en) *	2000-08-24	2002-03-04	Tim Ioannides	Topical antioxidant having vitamin c and method of combination with topical agent by user

2002
- 2002-02-07 FR FR0201510A patent/FR2835429B1/fr not_active Expired - Fee Related
2003
- 2003-02-04 DE DE60316209T patent/DE60316209T2/de not_active Expired - Lifetime
- 2003-02-04 ES ES03290275T patent/ES2292917T3/es not_active Expired - Lifetime
- 2003-02-04 AT AT03290275T patent/ATE372763T1/de not_active IP Right Cessation
- 2003-02-04 EP EP03290275A patent/EP1334714B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1334714A1 (de)	2003-08-13
DE60316209D1 (de)	2007-10-25
ES2292917T3 (es)	2008-03-16
DE60316209T2 (de)	2008-06-12
FR2835429B1 (fr)	2006-02-10
EP1334714B1 (de)	2007-09-12
FR2835429A1 (fr)	2003-08-08

Similar Documents

Publication	Publication Date	Title
ATE511753T1 (de)	2011-06-15	Postnatale stammzellen und deren verwendungen
DE60115842D1 (de)	2006-01-19	Ventilanordnung
ATE530179T1 (de)	2011-11-15	Verwendung von kreatin und/oder kreatinderivaten in dermatologischen zubereitungen
EP2824175A3 (de)	2015-05-06	Mesenchymale Stammzellen und Verwendungen dafür
ATE410998T1 (de)	2008-10-15	Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut
ATE286053T1 (de)	2005-01-15	Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
BR0007430A (pt)	2001-10-16	Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
WO2006014729A3 (en)	2007-01-04	Inhibitors of angiopoietin-like 4 protein, combinations, and their use
ATE356607T1 (de)	2007-04-15	Verwendung von nativem zein zur verbesserung des haarzustandes und mittel
SE0302923D0 (sv)	2003-11-06	Boswellin compositions enhanced with 3-beta-acetyl-11-keto- beta-boswellic acid (AKBA), industrial manufacture and their uses
DE602004031134D1 (de)	2011-03-03	Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE415962T1 (de)	2008-12-15	Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE542536T1 (de)	2012-02-15	3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen
NO20052494L (no)	2005-05-24	Preparater inneholdende melatonin, gingko biloba og biotin.
ATE410195T1 (de)	2008-10-15	Hydrokolloidzusammensetzungen
ATE368455T1 (de)	2007-08-15	Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE60316152D1 (de)	2007-10-18	Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
ATE372763T1 (de)	2007-09-15	Verwendung von ascorbinsäure zur verstärkung der dermo-epidermischen bindung
ATE499098T1 (de)	2011-03-15	Verwendung von parp-1-hemmern
DE60336187D1 (de)	2011-04-14	Verwendung von einem Extrakt von einem nicht-photosynthetischen faserigen Bakterium zur Beförderung der Herstellung von Superoxid-dismutase
EP1932513A3 (de)	2008-08-13	Zusammensetzungen zur Verbesserung des optischen Erscheinungsbildes der Haut
WO2007056352A3 (en)	2009-04-30	Compositions and methods for controlling tissue factor signaling specificity
DK1763363T3 (da)	2009-09-14	Farmaceutiske præparater indeholdende diaminooxidase
ATE340253T1 (de)	2006-10-15	Zellkonstrukte erhältlich aus mesenchymalen stammzellen und davon ableitbaren zellen und ihre verwendung
SE0101256D0 (sv)	2001-04-06	Treatment of low back pain

Legal Events

Date	Code	Title	Description
2008-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties